Skip to main content
. 2019 Dec 2;16:150. doi: 10.1186/s12985-019-1254-1

Fig. 3.

Fig. 3

Effective Inhibition Concentration (EIC50, mg/ml) of preparations against influenza virus type A. Actinomycetes extracts, K-192-1 N, K-192-2 N, K-192-2S, K-362-1S, K-362-2 N, K-525-2 N, K-525-2S inhibited neuraminidase activity of H3N2, H1N1, H5N3 and H7N1. The actinomycetes extract K-362-1S inhibited the neuraminidase activity of influenza virus strains resistant to commercial antiviral drugs (A/Vladivostok/2/09, H1N1 and A/tern/South Africa/1/61, H5N3)